SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
295.80    10.40 (3.64%)
Bid:
296.80
Ask:
297.40
Spread: 0.60 (0.202%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Trading Statement

25 Nov 2014 07:00

RNS Number : 8668X
Breedon Aggregates Ld
25 November 2014
 



 

News release

25 November 2014

BREEDON AGGREGATES LIMITED

("Breedon" or the "Group")

Trading Update

 

Trading Performance

 

Breedon continues to trade strongly, with both the recently acquired and underlying businesses making good progress. For the 10 months to October, sales volumes of aggregates increased by 26 per cent, asphalt by 12 per cent and ready-mixed concrete by 18 per cent compared to last year.

Group sales revenue for the 10 months to October increased by 20 per cent to £226 million. Assuming that weather conditions remain favourable for the remainder of the year, underlying EBITDA and underlying basic earnings per share for the full year are expected to be ahead of current market expectations1.

Operational progress & outlook

Our businesses in both England and Scotland have continued to make good progress, with product volumes in both countries ahead of last year and EBITDA margins improving. Trading conditions in England have continued to be strong, with high demand in our key markets. In Scotland conditions have been more subdued; however some areas such as Aberdeen have seen strong growth.

We are delighted to have invested around £40 million on acquisitions during the year to date and expect to improve the performance of these businesses as they become fully integrated with Breedon's existing operations.

The outlook remains positive, with a number of projects already secured for next year. Both the Construction Products Association and the Mineral Products Association are forecasting further market growth in the UK. In particular we expect some improvement in Scotland, with several large contracts starting in our market areas. We are confident of making further progress in 2015.

Cont/d…2

 

- 2 -

 

We will announce our preliminary results for the year to 31 December 2014 on 3 March 2015.

1 The range of analyst expectations for underlying EBITDA and underlying basic EPS are believed to be £34.8 million to £36.1 million and 1.30 pence to 1.46 pence respectively.

 

- ends -

 

Note to editors

Breedon Aggregates is the largest independent aggregates business in the UK after the four global majors. It operates 52 quarries, 27 asphalt plants, 61 ready-mixed concrete plants and three concrete block plants in England and Scotland and employs approximately 1,250 people. The group has strong asset backing, with more than 450 million tonnes of mineral reserves and resources in the UK. Breedon Aggregates' strategy is to grow organically and through consolidation of the UK heavyside building materials sector.

 

For further information:

 

Breedon Aggregates Limited

Simon Vivian, Group Chief Executive

Rob Wood, Group Finance Director

01332 694010

 

Stephen Jacobs, Head of Communications

07831 764592

 

Cenkos Securities plc (Nomad & joint broker)

Max Hartley / Nicholas Wells 020 7397 8900

 

Peel Hunt (joint broker)

Justin Jones / Mike Bell 020 7418 8900

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDZLFLZFFXFBV
Date   Source Headline
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights
31st May 202311:30 amRNSHolding(s) in Company
24th May 202312:35 pmRNSDirector/PDMR Shareholding
23rd May 20235:31 pmRNSHolding(s) in Company
22nd May 202311:24 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
18th May 20234:52 pmRNSDirector/PDMR Shareholding
18th May 20239:00 amRNSBreedon plays key role in Peak Cluster initiative
18th May 20238:00 amRNSAcquisitions
17th May 20238:00 amRNSReadmission - Breedon Group plc
17th May 20237:00 amRNSAdmission to Main Market
12th May 20236:00 pmRNSBreedon Group
12th May 20233:50 pmRNSDirector/PDMR Shareholding
11th May 202312:56 pmRNSPublication of Prospectus
4th May 202310:06 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSHolding(s) in Company
26th Apr 20234:41 pmRNSResult of Scheme Meetings & Annual General Meeting
26th Apr 20237:00 amRNSAGM Trading Update
24th Apr 20232:22 pmRNSHolding(s) in Company
13th Apr 20236:08 pmRNSHolding(s) in Company
13th Apr 202312:12 pmRNSHolding(s) in Company
12th Apr 20234:50 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSPublication of Scheme Document
24th Mar 20233:49 pmRNSHolding(s) in Company
20th Mar 20239:00 amRNS2022 Annual Report and Notice of AGM
10th Mar 20235:34 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSResults of Reverse Accelerated Bookbuild
9th Mar 20234:56 pmRNSStatement re Reverse Accelerated Bookbuild
9th Mar 20231:36 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSIntention to move from AIM to the Main Market
8th Mar 20237:00 amRNSFinal Results
8th Feb 20238:00 amRNSNotice of Results
6th Feb 20231:29 pmRNSDirector/PDMR Shareholding
6th Jan 202310:08 amRNSBlocklisting Update
23rd Dec 202210:00 amRNSTotal Voting Rights
19th Dec 202212:57 pmRNSHolding(s) in Company
2nd Dec 20224:01 pmRNSHolding(s) in Company
30th Nov 20229:28 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSNovember trading statement
27th Oct 20224:23 pmRNSStandard form for notification of major holdings
26th Oct 20229:18 amRNSNotice of trading update
3rd Oct 20223:27 pmRNSPDMR Dealings
30th Sep 20224:20 pmRNSDirector Dealings
23rd Sep 20225:09 pmRNSStandard form for notification of major holdings
6th Sep 20225:19 pmRNSStandard form for notification of major holdings
25th Aug 20224:13 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSInterim results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.